New research into cancer growth has pinpointed a mechanism that impacts the aggressiveness of breast cancer tumors, according to a Scripps Research Institute study published in the Journal of Clinical Investigation.
It’s an important finding because doctors often find it difficult to figure out if a particular tumor will become aggressive — a determination which can affect treatment.
Scientists have been able to use the research to impede the growth of cancer in mice and prolong life, and they hope to quickly begin trials in humans.
Luckily nicotinamide, a B-complex vitamin which is used to slow the growth, is already used to treat cholesterol and skin diseases — meaning that the approval process for clinical trials likely won’t be quite as difficult, according to the San Diego Union Tribune.
[Image via AFP]